Japan med; iPS retinal cell transplant surgery: “retinitis pigmentosa”
Intractable eye disease:
Transplant retinal cells made from iPS cells into patients with “retinitis pigmentosa”.
The world’s first surgery was performed by Kobe City Eye Center Hospital.
iPS Retinal Cell Transplant Surgery:
Surgery
Using iPS cells made from healthy people
Transform into cells that sense light,
Produce a sheet with a diameter of 1 mm and a thickness of 0.2 mm,
The sheet is transplanted into the patient’s retina.
Kobe Eye Center Hospital:
This photoreceptor transplantation is the first step toward “a treatment method for patients with retinitis pigmentosa that has never been treated before.”
“Retinitis pigmentosa”:
A disease in which the field of vision gradually narrows and blindness may occur.
It is estimated that there are about 30,000 patients in Japan.
There is currently no cure.
If safety can be confirmed, it will be the first step toward establishing a future treatment method.
MBS Kansai News
https://www.mbs.jp/news/kansainews/20201016/GE00035298.shtml
Autologous iPS cell-derived retinal pigment epithelial sheet transplantation for age-related macular degeneration
-Published clinical research results for safety verification-
https://www.riken.jp/press/2017/20170316_1/